We are live on ! Find out more
ICP

Interchange Capital Partners Portfolio holdings

AUM $532M
1-Year Est. Return 26.57%
This Fund
S&P 500
This Quarter Est. Return
+3.84%
1 Year Est. Return
+26.57%
3 Year Est. Return
+79.59%
5 Year Est. Return
+78.72%
10 Year Est. Return
AUM
$277M
AUM Growth
-$7.16M
Cap. Flow
-$10.5M
Cap. Flow %
-3.79%
Top 10 Hldgs %
26.28%
Holding
306
New
23
Increased
63
Reduced
164
Closed
41

Sector Composition

Rank Sector Weight
1 Technology 16.09%
2 Financials 7.45%
3 Healthcare 6.97%
4 Consumer Discretionary 6.88%
5 Communication Services 5.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XBI icon
301
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.2B
-300
Closed -$29.6K
XBI icon
302
State Street SPDR S&P Biotech ETF
XBI
$10.2B
-3,486
Closed -$344K
XLF icon
303
PUT
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
-600
Closed -$27.2K
XLY icon
304
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.6B
-2,096
Closed -$210K
ZTS icon
305
Zoetis
ZTS
$32.2B
-1,946
Closed -$380K
ETH
306
Grayscale Ethereum Staking Mini ETF Shares
ETH
$1.78B
-4,585
Closed -$112K

Similar funds

Interchange Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Interchange Capital Partners held 306 positions worth $277M, down 2.5% from $284M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Interchange Capital Partners withdrew a net $10.5M in Q4 2024, closing 41 positions and reducing 164 holdings. Its most notable exit was CVS Health, an estimated $861K position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Interchange Capital Partners opened a new position in Medicus Pharma worth $3.63M.

  • Interchange Capital Partners's largest Q4 2024 buy was Medicus Pharma: 1,457,165 shares worth $3.63M.
  • Interchange Capital Partners added most to JPMorgan Ultra-Short Municipal Income ETF in Q4 2024, an estimated $2.62M increase.
  • Interchange Capital Partners's biggest Q4 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $790K.
  • Interchange Capital Partners fully exited CVS Health in Q4 2024, selling an estimated $861K.
  • Interchange Capital Partners's ten largest holdings make up 26% of its $277M portfolio in Q4 2024.
  • Interchange Capital Partners opened 23 new positions and closed 41 in Q4 2024.
  • Interchange Capital Partners's portfolio value fell 2.5% quarter-over-quarter to $277M.

Based on Interchange Capital Partners's 13F filing for Q4 2024, filed 11 Feb 2025.